tirzepatide surmount-1 nejm 2022 weight loss percent First head-to-head trial compares and semaglutide - Results are in! SURMOUNT 1 // Three-Year Obesty
Description
Mounjaros drug label recommends using a non-oral contraceptive method or adding a barrier contraceptive for four weeks after starting treatment and for four weeks after each dose escalation

This central action contributes to weight loss by reducing hunger and caloric intake

Compared to placebo, it has been shown to significantly lower HbA1c by up to 2.07% when administered as a once-weekly subcutaneous injection at a maximum dose of 15 mg

But not zero

Recalculate your units based on your current vial concentration

For more context on tirzepatide pricing, see our guide on affordable tirzepatide options
